| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $1.8M | -71.3% |
| SG&A Expense | $16.3M | +78.9% |
| Operating Income | -$18.0M | -18.5% |
| Interest Expense | $1.2M | -21.6% |
| Pre-tax Income | -$22.3M | -34.5% |
| Income Tax | -$173K | — |
| Net Income | -$22.1M | -33.4% |
| EPS (Diluted) | -$0.39 | +95.0% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.8M | +183.6% |
| Current Assets | $9.8M | +213.7% |
| Total Assets | $125.1M | +3313.3% |
| Current Liabilities | $3.7M | -27.6% |
| Total Liabilities | $28.0M | +380.4% |
| Stockholders' Equity | $97.1M | +4604.2% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.6M | +40.8% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $13.3M | +66.7% |
| Free Cash Flow | -$7.6M | +41.1% |